Search results for "Platelet concentrate"

showing 9 items of 9 documents

Positive effect of platelet rich fibrin on osseointegration

2016

Background Leukocyte-platelet rich fibrin (L-PRF) is a second generation platelet concentrate clinically used to accelerate tissue healing and bone regeneration. Achieving reduced implant osseointegration time could provide immediate or early loading of implants. The aim of this study was to evaluate the L-PRF-induced osseointegration and bone-implant contact (BIC) in an experimental animal model. Material and Methods Twelve 4-month-old New Zealand white rabbits were used. Following general anesthesia, 3-5 mL of blood was obtained from the central artery in rabbit ear and L-PRF was prepared. Two implant cavities (5 mm long and 3 mm in diameter) were created in each tibia with a total of fou…

0106 biological sciencesBone RegenerationDentistry01 natural sciencesOsseointegrationFibrin03 medical and health sciences0302 clinical medicineOsseointegrationPlatelet-Rich Fibrin010608 biotechnologyEarly loadingAnimalsMedicinePlatelet concentrateBone regenerationMatrix for growth factorsGeneral DentistryDental ImplantsFibrinbiologybusiness.industryResearch030206 dentistry:CIENCIAS MÉDICAS [UNESCO]digestive system diseasesPlatelet-rich fibrinExperimental animalOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASbiology.proteinSurgeryRabbitsImplantOral SurgerybusinessPlatelet rich fibrinMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Platelet Pathogen Reduction Technologies Alter the MicroRNA Profile of Platelet-Derived Microparticles

2020

Despite improvements in donor screening and increasing efforts to avoid contamination and the spread of pathogens in clinical platelet concentrates (PCs), the risks of transfusion-transmitted infections remain important. Relying on an ultraviolet photo activation system, pathogen reduction technologies (PRTs), such as Intercept and Mirasol, utilize amotosalen, and riboflavin (vitamin B2), respectively, to mediate inactivation of pathogen nucleic acids. Although they are expected to increase the safety and prolong the shelf life of clinical PCs, these PRTs might affect the quality and function of platelets, as recently reported. Upon activation, platelets release microparticles (MPs), which …

0301 basic medicineAmotosalenmedicine.medical_specialtySmall RNAlcsh:Diseases of the circulatory (Cardiovascular) systemmirasolCardiovascular Medicine030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineclinical platelet concentrateInternal medicinemicroRNAmedicinePlateletHematologiPathogenOriginal ResearchRegulation of gene expressionHematologymicroRNApathogen reductionChemistryclinical platelet concentrate; pathogen reduction; mirasol; intercept; extracellular vesicles; small RNA-sequencing; microRNAHematology3. Good healthCell biologysmall RNA-sequencing030104 developmental biologylcsh:RC666-701extracellular vesiclesCardiology and Cardiovascular MedicineFunction (biology)interceptFrontiers in Cardiovascular Medicine
researchProduct

Peculiarities of studying the effects of pathogen reduction technologies on platelets.

2016

The transfusion of platelet concentrates (PCs) is mainly used for treatment of thrombocytopenic, trauma or surgery patients. The integrity and safety of these platelet preparations, however, is compromised by the presence of pathogens, such as viruses, bacteria and parasites. The transfer of allogeneic donor leukocytes contaminating PCs can also potentially cause adverse reactions in recipients. These considerations prompted the development and implementation of pathogen reduction technologies (PRT), which are based on chemically induced cross-linking and inactivation of nucleic acids. While the incumbent PRT may provide some protection against transfusion-transmitted infections, they are i…

0301 basic medicineBlood PlateletsProteomicsmedicine.medical_specialtyFuture studiesClinical BiochemistryBlood preservationfood and beveragesPathogen reductionTransfusion medicine030204 cardiovascular system & hematologyBiology03 medical and health sciencesFunctional integrity030104 developmental biology0302 clinical medicineBlood PreservationImmunologymedicineAnimalsHumansPlateletBlood TransfusionPlatelet concentrateTranscriptomeProteomics. Clinical applications
researchProduct

Platelet-Rich Plasma: A Study of the Variables that May Influence Its Effect on Bone Regeneration

2015

Background Currently, the use of platelet-rich plasma in bone regeneration is a real option, although more than one opinion has alerted us to the absence of clinical benefits. Purpose Analysis of the factors able to modify the characteristics of the platelet preparation obtained by Curasan, Plasma Rich in Growth Factors (PRGF), Platelet Concentrate Collection System (PCCS) and SmartPrep systems, relating them to the type of clinical application and the final bone regeneration achieved. Materials and Methods A search was conducted in PubMed using the keywords “platelet-rich plasma,” “PRP,” “platelet rich growth factors,” and “oral bone regeneration.” Four widely accepted protocols for the ob…

0301 basic medicinemedicine.medical_specialtybusiness.industryOral surgeryDentistry030206 dentistryCollection systemSurgery03 medical and health sciences030104 developmental biology0302 clinical medicinePlatelet-rich plasmamedicinePlateletPlatelet concentrateOral SurgeryBone regenerationbusinessGeneral DentistryClinical Implant Dentistry and Related Research
researchProduct

L-PRF application in extraction sockets of bisphosphonate-treated patients: preliminary results

2016

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a severe adverse event related to bisphosphonates (BPs) therapy; tooth extraction has been described as the main trigger. Autologous platelet concentrates, such Leukocyte-Platelet Rich Fibrin (L-PRF, Intraspin !) are designed to release platelet growth factors, improving the tissue healing in oral surgery. The aim of this study was to evaluate the efficacy and safety of our dental extraction protocol applied in BPs patients.

Bisphosphonate-related osteonecrosis of the jaw Autologus platelet concentrates Leukocyte-Platelet Rich Fibrin dental extraction
researchProduct

Quantification of growth factors by using a new system for obtaining platelet-rich plasma

2010

Objective: To verify the performance of a new method for obtaining platelet-rich plasma, while avoiding contami- nation of the sample during its processing. Study Design: Twenty healthy patients were selected, from whom 21 ml of blood was etracted. �e then pro- Design: Twenty healthy patients were selected, from whom 21 ml of blood was etracted. �e then pro- esign: Twenty healthy patients were selected, from whom 21 ml of blood was etracted. �e then pro- ceeded to study the platelets and growth factors in basal blood after centrifuging the sample by using a new closed system for obtaining platelet-rich plasma (PRP). Results: After centrifuging the blood sample, double the amount of platelet…

ChemistryPlatelet-Rich PlasmaGrowth factormedicine.medical_treatmentInsulinCentrifugationHematology:CIENCIAS MÉDICAS [UNESCO]AndrologyYoung AdultOtorhinolaryngologyBasal (medicine)Platelet-rich plasmaImmunologyUNESCO::CIENCIAS MÉDICASmedicineHumansIntercellular Signaling Peptides and ProteinsSurgeryPlateletPlatelet concentrateSistema circulatorioGeneral DentistryTransforming growth factor
researchProduct

Autologous adipose-derived stromal vascular fraction and platelet concentrates for the treatment of complex perianal fistulas

2022

Abstract Background Complex perianal fistulas are a major challenge for modern surgery since 10–35% of patients have functional problems after treatment. Sphincter-saving techniques have a wide range of efficacy (10–80%). We hypothesised that autologous adipose-derived stromal vascular fraction in combination with platelet rich plasma is a new therapeutic strategy with enhanced cure and function preservation rates. Methods Adult patients with complex cryptoglandular perianal fistulas were treated with injection of autologous adipose-derived stromal vascular fraction in combination with platelet rich plasma around and inside the fistulous tract between May 2018 and April 2019 at the General …

CryptoglandularPlatelet concentratesGastroenterologySurgerySettore MED/46 - Scienze Tecniche Di Medicina Di LaboratorioPerianal fistulaStromal cellsTechniques in Coloproctology
researchProduct

Clinical effectiveness of platelet concentrates for periodontal regeneration

2016

Settore MED/28 - Malattie Odontostomatologicheperiodontal regeneration platelet concentrate
researchProduct

Platelet-rich fibrin for wound healing of palatal donor sites of free gingival grafts: Systematic review and meta-analysis.

2020

Made available in DSpace on 2021-06-25T10:22:28Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01 Background: Platelet-rich fibrin (PRF) has been referred to as a second-generation platelet concentrate, associated with improvements on the healing of palatal wounds followed by FGG harvesting. The aim of this systematic review and meta-analysis was to assess the complete wound epithelialization and postoperative pain when PRF was used in palatal wounds following free gingival graft (FGG) harvesting. Material and Methods: PubMed (Medline), EMBASE and Scopus were searched by two independent individuals up to and including March 2020 in order to identify controlled and randomized cont…

medicine.medical_specialtyCochrane collaborationbiologybusiness.industryOral surgeryWound healingReviewFibrinPlatelet-rich fibrinSurgeryClinical trialoral surgery proceduresMeta-analysisbiology.proteinpostoperativeMedicinepainPeriodontologyPlatelet concentratebusinessWound healingGeneral DentistryUNESCO:CIENCIAS MÉDICASJournal of clinical and experimental dentistry
researchProduct